| Table 2.1.Summary of selected global strategieson communicable diseases |
|
|
| <table> |
| <thead> |
| <tr> |
| <th> |
| </th> |
| <th> |
| Milestones |
| </th> |
| <th> |
| 2030 Goal |
| </th> |
| <th> |
| 2030 SDG target |
| </th> |
| </tr> |
| </thead> |
| <tbody> |
| <tr> |
| <td colspan="4"> |
| End TB strategy (8) |
| </td> |
| </tr> |
| <tr> |
| <td> |
| TB deaths |
| </td> |
| <td> |
| 2020: ↓ 35%\[^{*}\] |
| <br> |
| 2025: ↓ 75% |
| </td> |
| <td> |
| ↓ 95% |
| </td> |
| <td rowspan="3"> |
| “Endthe epidemic of TB |
| <br> |
| across all countries" |
| </td> |
| </tr> |
| <tr> |
| <td> |
| TB incidence rate |
| </td> |
| <td> |
| 2020: ↓ 20% |
| <br> |
| 2025: 150% |
| </td> |
| <td> |
| ↓ 80% |
| </td> |
| </tr> |
| <tr> |
| <td> |
| TB-affected familiesfacing catastrophic costs due to TB(%) |
| </td> |
| <td> |
| 2020: 0% |
| <br> |
| 2025: 0% |
| </td> |
| <td> |
| 0% |
| </td> |
| </tr> |
| <tr> |
| <td colspan="4"> |
| Global healthsector strategy on HV 2016-2021 (9) |
| </td> |
| </tr> |
| <tr> |
| <td> |
| New HIV infections |
| </td> |
| <td> |
| 2020: <500000/year |
| </td> |
| <td> |
| ↓ 90% |
| </td> |
| <td rowspan="2"> |
| “Endthe epidemic ofHIV |
| <br> |
| across all countries” |
| </td> |
| </tr> |
| <tr> |
| <td> |
| AIDS-related deaths |
| </td> |
| <td> |
| 2020: <500000/year |
| </td> |
| <td> |
| ↓ 90% |
| </td> |
| </tr> |
| <tr> |
| <td colspan="4"> |
| Gobal AIDS strategy 2021-2026 (10) |
| </td> |
| </tr> |
| <tr> |
| <td> |
| New HIV infections |
| </td> |
| <td> |
| 2025: <370000/year |
| </td> |
| <td> |
| ↓ 90% |
| </td> |
| <td rowspan="2"> |
| “End the epidemic of HIV |
| <br> |
| across all countries” |
| </td> |
| </tr> |
| <tr> |
| <td> |
| AIDS-related deaths |
| </td> |
| <td> |
| 2025: <250000/year |
| </td> |
| <td> |
| ↓ 90% |
| </td> |
| </tr> |
| <tr> |
| <td colspan="4"> |
| Global technical strategy for malara 2016-2030 (11) |
| </td> |
| </tr> |
| <tr> |
| <td> |
| Malariaincidence |
| </td> |
| <td> |
| 2020: ↓ 40% (at least) |
| <br> |
| 2025: ↓ 75% (at least) |
| </td> |
| <td> |
| ↓ 90% (at least) |
| </td> |
| <td rowspan="3"> |
| “End the malaria epidemic |
| <br> |
| across all countries” |
| </td> |
| </tr> |
| <tr> |
| <td> |
| Malaria deaths |
| </td> |
| <td> |
| 2020: ↓ 40% (at least) |
| <br> |
| 2025: ↓ 75% (at least) |
| </td> |
| <td> |
| ↓ 90% (at least) |
| </td> |
| </tr> |
| <tr> |
| <td> |
| Countries eliminating malaria |
| </td> |
| <td> |
| 2020: 10 countries |
| <br> |
| 2025: 20 countries |
| </td> |
| <td> |
| 35 countries |
| </td> |
| </tr> |
| <tr> |
| <td colspan="4"> |
| Road map for neglected tropical diseases (NTDs)2021-2030(12) |
| </td> |
| </tr> |
| <tr> |
| <td> |
| People requiring interventions against NTDs |
| </td> |
| <td rowspan="4"> |
| Disease-specific targets set |
| <br> |
| for each NTD include 2023 |
| <br> |
| and 2025 milestones |
| </td> |
| <td> |
| ↓ 90% |
| </td> |
| <td rowspan="4"> |
| “End the NTDs epidemics |
| <br> |
| across all countries” |
| </td> |
| </tr> |
| <tr> |
| <td> |
| Disability-adjusted lifeyears related to NTDs |
| </td> |
| <td> |
| ↓ 75% |
| </td> |
| </tr> |
| <tr> |
| <td> |
| Countries eliminating at leastone neglected tropical disease |
| </td> |
| <td> |
| 100 |
| </td> |
| </tr> |
| <tr> |
| <td> |
| NTDs eradicated |
| </td> |
| <td> |
| 2 |
| </td> |
| </tr> |
| <tr> |
| <td colspan="4"> |
| Polio endgame strategy 2019-2023 (13) |
| </td> |
| </tr> |
| <tr> |
| <td> |
| Wild poliovirus transmission |
| </td> |
| <td> |
| 2030: Eradication of polio |
| </td> |
| <td> |
| </td> |
| <td> |
| </td> |
| </tr> |
| </tbody> |
| </table> |
|
|
| Note: \[^{*}\]% dedines arerelative to 2015 baselines. |